---
title: "Zuclopenthixol - Schizophrenia"
sidebar: mydoc_sidebar
permalink: db01624-mesh-d012559-1.html
toc: false 
---


Path ID: `DB01624_MESH_D012559_1`
{% include image.html url="images/db01624-mesh-d012559-1.png" file="db01624-mesh-d012559-1.png" alt="db01624-mesh-d012559-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D003006 | zuclopenthixol | Drug |
| UniProt:P14416 | D(2) dopamine receptor | Protein |
| UniProt:P21918 | D(1B) dopamine receptor | Protein |
| UniProt:P21728 | D(1A) dopamine receptor | Protein |
| MESH:D004298 | Dopamine | ChemicalSubstance |
| GO:0061527 | Dopamine secretion, neurotransmission | BiologicalProcess |
| MESH:D012559 | Schizophrenia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Zuclopenthixol | DECREASES ACTIVITY OF | D(2) Dopamine Receptor |
| Zuclopenthixol | DECREASES ACTIVITY OF | D(1B) Dopamine Receptor |
| Zuclopenthixol | DECREASES ACTIVITY OF | D(1A) Dopamine Receptor |
| D(2) Dopamine Receptor | POSITIVELY CORRELATED WITH | Dopamine |
| D(1B) Dopamine Receptor | POSITIVELY CORRELATED WITH | Dopamine |
| D(1A) Dopamine Receptor | POSITIVELY CORRELATED WITH | Dopamine |
| Dopamine | POSITIVELY CORRELATED WITH | Dopamine Secretion, Neurotransmission |
| Dopamine Secretion, Neurotransmission | AFFECTED BY | Schizophrenia |
|---------|-----------|---------|

Reference: 
  - [https://pubchem.ncbi.nlm.nih.gov/compound/5566](https://pubchem.ncbi.nlm.nih.gov/compound/5566)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032934/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032934/)
  - [https://go.drugbank.com/drugs/DB01624#BE0000020](https://go.drugbank.com/drugs/DB01624#BE0000020)
